DVA News and Press, DaVita Inc. From 04/29/21

DaVita HealthCare Partners (DVA): Q1 GAAP EPS of $2.09 beats by $0.25.Revenue of $2.82B (-0.7% Y/Y) in-line.FY21 Guidance:Press Release For further details see: DaVita HealthCare Partners EPS beats by $0.25, revenue in-line

DaVita Inc. 1st Quarter 2021 Results PR Newswire DENVER , April 29, 2021 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended March 31, 2021. For the quarter, diluted earnings per share from continu...

DaVita Solidifies Commitment to ESG, Sets 2025 Goals Company unifies its holistic support for patients, teammates and communities under ESG PR Newswire DENVER , April 27, 2021 /PRNewswire/ -- DaVita Inc. today announced its 2025 Environmental, Social and...

DaVita Inc. Schedules 1st Quarter 2021 Investor Conference Call PR Newswire DENVER , April 22, 2021 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss first quarter results on Thursday, ...

CYH is the all-American general acute care operator providing a range of health care services States-side. The health care venture kicks off its earnings on 28 April after market close. As one of the largest publicly-owned hospital operators in the US, the $1.48B venture showcases...

A dashboard with metrics in healthcare industries. Value and quality scores, and their evolution since last month. A list of cheap stocks. Short review of IDNA. For further details see: Healthcare Dashboard For April And Focus On IDNA

Blue Cross and Blue Shield of Minnesota Launches Program with DaVita's VillageHealth to Improve Care for Members with Kidney Disease Collaboration aimed at slowing disease progression and increasing access to transplants and home dialysis PR Newswire EAGAN, Minn. ...

DaVita Shares Strategy for Achieving a Diverse Community Where Everyone Belongs Kidney care company continues its journey to create a vibrant environment where all teammates can thrive PR Newswire DENVER , March 29, 2021 /PRNewswire/ -- DaVita today publi...

BofA Securities analyst Kevin Fischbeck has downgraded shares of DaVita (DVA) to underperform from neutral and is cutting his price target from $127 to $118.He writes that the company is not as "levered" as its competitors in terms of being prepared for an expected modest increase in patients...

Aspira Women's Health (AWH) has extended the post-market gains with a ~12.2% rise in the pre-market as analysts weigh in on its new agreement to develop an early detection test for ovarian cancer.“We support the notion of the team taking another big swing and working to ...